EDIT:NASDAQ
Editas Medicine Inc
1,73 $
arrow_upward
+1,17%(+0,020) 1D
20 նոյ, 10:59:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,69 $
High
1,78 $
Low
1,66 $
Mkt. cap
267,01 մլն
Avg. vol.
2,24 մլն
Volume
421,62 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,69 $
High
1,78 $
Low
1,66 $
Mkt. cap
267,01 մլն
Avg. vol.
2,24 մլն
Volume
421,62 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
Barron's
·
1 ժամ առաջ
S&P 500 Skid Enters Seventh Day as Dow Nears Correction
ChartMill
·
2 ժամ առաջ
S&P 500 Premarket Movers Friday: Gainers and Losers
marketscreener.com
·
3 ժամ առաջ
Societe Generale sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc